These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31302391)

  • 1. Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy.
    Peeken JC; Molina-Romero M; Diehl C; Menze BH; Straube C; Meyer B; Zimmer C; Wiestler B; Combs SE
    Radiother Oncol; 2019 Sep; 138():166-172. PubMed ID: 31302391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data.
    Witulla B; Goerig N; Putz F; Frey B; Engelhorn T; Dörfler A; Uder M; Fietkau R; Bert C; Laun FB
    PLoS One; 2020; 15(1):e0227146. PubMed ID: 31905221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor magnetic resonance imaging driven growth modeling for radiotherapy target definition in glioblastoma.
    Jensen MB; Guldberg TL; Harbøll A; Lukacova S; Kallehauge JF
    Acta Oncol; 2017 Nov; 56(11):1639-1643. PubMed ID: 28893125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonography: integration into target volume definition for glioblastoma multiforme.
    Vordermark D; Becker G; Flentje M; Richter S; Goerttler-Krauspe I; Koelbl O
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):565-71. PubMed ID: 10837937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion tensor imaging for target volume definition in glioblastoma multiforme.
    Berberat J; McNamara J; Remonda L; Bodis S; Rogers S
    Strahlenther Onkol; 2014 Oct; 190(10):939-43. PubMed ID: 24823897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
    Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
    J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
    Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
    Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing the radiotherapy target volume for glioblastoma using DTI-MRI: a phase 0 study on coverage of recurrences.
    Trip AK; Jensen MB; Kallehauge JF; Lukacova S
    Acta Oncol; 2019 Oct; 58(10):1532-1535. PubMed ID: 31303079
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.
    Lipkova J; Angelikopoulos P; Wu S; Alberts E; Wiestler B; Diehl C; Preibisch C; Pyka T; Combs SE; Hadjidoukas P; Van Leemput K; Koumoutsakos P; Lowengrub J; Menze B
    IEEE Trans Med Imaging; 2019 Aug; 38(8):1875-1884. PubMed ID: 30835219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo based formalism to identify potential locations at high risk of tumor recurrence with a numerical model for glioblastoma multiforme.
    Trepanier PY; Fortin I; Lambert C; Lacroix F
    Med Phys; 2012 Nov; 39(11):6682-91. PubMed ID: 23127062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any additional benefit of
    Şahin M; Akgun E; Sirolu S; Can G; Sayman HB; Oner Dincbas F
    Br J Radiol; 2022 Oct; 95(1139):20220049. PubMed ID: 35993417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
    Piroth MD; Galldiks N; Pinkawa M; Holy R; Stoffels G; Ermert J; Mottaghy FM; Shah NJ; Langen KJ; Eble MJ
    Radiat Oncol; 2016 Jun; 11():87. PubMed ID: 27342976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
    Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
    Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.
    Lee SW; Fraass BA; Marsh LH; Herbort K; Gebarski SS; Martel MK; Radany EH; Lichter AS; Sandler HM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):79-88. PubMed ID: 9989517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
    Harat M; Małkowski B; Makarewicz R
    Radiother Oncol; 2016 Aug; 120(2):241-7. PubMed ID: 27378734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.